Difficulty: Medium
Average Score: 82%
Practice
A nurse working in an outpatient clinic plans a screening program for diabetes. What recommendations for screening should be included?
Correct answer
B
Rationale
The correct answer is B) FPG for all individuals at age 45 and then every 3 years. This recommendation aligns with the guidelines from major health organizations like the American Diabetes Association, which suggests screening for diabetes in asymptomatic adults starting at age 45, and then every 3 years thereafter. This approach is evidence-based and cost-effective in identifying individuals at risk for diabetes.
Option A) OGTT for all minority populations every year is not recommended as a routine screening test for diabetes in asymptomatic individuals. OGTT is more invasive, time-consuming, and costly compared to FPG, making it less feasible for widespread screening programs.
Option C) Testing people under the age of 21 for islet cell antibodies is not a standard screening method for diabetes in the general population. Islet cell antibodies are more relevant in the context of autoimmune type 1 diabetes and are not routinely used for mass screening purposes.
Option D) Testing for type 2 diabetes in all overweight or obese individuals is not as specific or efficient as the age-based screening recommended in option B. While obesity is a risk factor for type 2 diabetes, screening solely based on weight status may miss individuals who develop diabetes at a younger age or those with normal weight but other risk factors.
In an educational context, understanding the rationale behind age-appropriate screening recommendations for diabetes is crucial for healthcare professionals to provide evidence-based care. By following established guidelines, nurses can effectively identify individuals at risk for diabetes, initiate early interventions, and promote better health outcomes. It is essential for healthcare providers to stay updated on screening recommendations to deliver high-quality patient care.
Option A) OGTT for all minority populations every year is not recommended as a routine screening test for diabetes in asymptomatic individuals. OGTT is more invasive, time-consuming, and costly compared to FPG, making it less feasible for widespread screening programs.
Option C) Testing people under the age of 21 for islet cell antibodies is not a standard screening method for diabetes in the general population. Islet cell antibodies are more relevant in the context of autoimmune type 1 diabetes and are not routinely used for mass screening purposes.
Option D) Testing for type 2 diabetes in all overweight or obese individuals is not as specific or efficient as the age-based screening recommended in option B. While obesity is a risk factor for type 2 diabetes, screening solely based on weight status may miss individuals who develop diabetes at a younger age or those with normal weight but other risk factors.
In an educational context, understanding the rationale behind age-appropriate screening recommendations for diabetes is crucial for healthcare professionals to provide evidence-based care. By following established guidelines, nurses can effectively identify individuals at risk for diabetes, initiate early interventions, and promote better health outcomes. It is essential for healthcare providers to stay updated on screening recommendations to deliver high-quality patient care.